Literature DB >> 8857930

Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin.

C Rogers1, F G Welt, M J Karnovsky, E R Edelman.   

Abstract

Among the many effects of heparin independent of its effects on coagulation are inhibition of vascular smooth muscle cell proliferation and regulation of leukocyte-blood vessel interactions. The potential link between these effects was examined in an animal model of vascular injury rich in inflammatory cells: the placement of endovascular metal stents in rabbit iliac arteries. Monocyte adhesion stimulated by early focal thrombus was maximal after 3 days, with infiltrating monocytes and intimal cell proliferation maximal after 7 days. Tissue monocyte number dictated cell proliferation at each time point (R2 = .92, P < .0001). Heparin reduced both early monocyte adhesion as well as monocyte infiltration within the neointima 7 and 14 days after stent placement. Reductions in adherent and tissue monocytes were commensurate with reductions in intimal cell proliferation and intimal thickening. At 14 days, heparin's inhibition of mononuclear cell adhesion was correlated with its suppression of intimal thickening (R2 = .82, P < .0001). Monocytes have been hypothesized to serve as markers, initiators, and promoters of arterial occlusive diseases. Heparin's ability to inhibit mononuclear cell adhesion and penetration and reduce neointimal size and cell proliferation after vascular injury may further implicate monocytes in the pathogenesis of neointimal hyperplasia after mechanical arterial injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8857930     DOI: 10.1161/01.atv.16.10.1312

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  37 in total

1.  Primary monocytes regulate endothelial cell survival through secretion of angiopoietin-1 and activation of endothelial Tie2.

Authors:  Shai Y Schubert; Alejandro Benarroch; Juan Monter-Solans; Elazer R Edelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-27       Impact factor: 8.311

2.  TLR3 and TLR4 as potential clinical biomarkers for in-stent restenosis in drug-eluting stents patients.

Authors:  Shao Liang; Ma Aiqun; Li Jiwu; Zhang Ping
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

3.  CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury.

Authors:  Guohong Li; John M Sanders; Melissa H Bevard; Zhiqi Sun; James W Chumley; Elena V Galkina; Klaus Ley; Ian J Sarembock
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

4.  In vivo Evaluation of Cenderitide-Eluting Stent (CES) II.

Authors:  Yingying Huang; Xu Wen Ng; Soon Ghim Lim; Horng Haur Chen; John C Burnett; Yin Chiang Freddy Boey; Subbu S Venkatraman
Journal:  Ann Biomed Eng       Date:  2015-07-16       Impact factor: 3.934

Review 5.  A2 adenosine receptors and vascular pathologies.

Authors:  Hillary A Johnston-Cox; Milka Koupenova; Katya Ravid
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04       Impact factor: 8.311

6.  Granulation encapsulated stent: a new therapeutic approach for vascular implantation.

Authors:  Lilong Tang; Xiaochao Chen; Shuangbo Tang; Thomas LaLonde; Julius M Gardin
Journal:  Heart       Date:  2006-08-16       Impact factor: 5.994

7.  Central role of RAGE-dependent neointimal expansion in arterial restenosis.

Authors:  Taichi Sakaguchi; Shi Fang Yan; Shi Du Yan; Dmitri Belov; Ling Ling Rong; Monica Sousa; Martin Andrassy; Steven P Marso; Stephan Duda; Bernd Arnold; Birgit Liliensiek; Peter P Nawroth; David M Stern; Ann Marie Schmidt; Yoshifumi Naka
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

8.  Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: COLCHICINE-PCI Randomized Trial.

Authors:  Binita Shah; Michael Pillinger; Hua Zhong; Bruce Cronstein; Yuhe Xia; Jeffrey D Lorin; Nathaniel R Smilowitz; Frederick Feit; Nicole Ratnapala; Norma M Keller; Stuart D Katz
Journal:  Circ Cardiovasc Interv       Date:  2020-04-16       Impact factor: 6.546

9.  A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits.

Authors:  C Rogers; E R Edelman; D I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

10.  Lesion complexity determines arterial drug distribution after local drug delivery.

Authors:  Abraham R Tzafriri; Neda Vukmirovic; Vijaya B Kolachalama; Irina Astafieva; Elazer R Edelman
Journal:  J Control Release       Date:  2009-11-17       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.